Projected Income Statement: CONMED Corporation

Forecast Balance Sheet: CONMED Corporation

Forecast Balance Sheet - CONMED Corporation
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 664 1,026 950 881 794 742 646 532
Change - 54.52% -7.41% -7.26% -9.88% -6.56% -12.94% -17.65%
Announcement Date 26/1/22 2/2/23 31/1/24 5/2/25 28/1/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: CONMED Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 14.87 21.78 19.03 13.08 19.81 19 27 28
Change - 46.54% -12.64% -31.25% 51.38% -4.07% 42.11% 3.7%
Free Cash Flow (FCF) 1 96.9 11.58 106.3 153.9 150.9 215 164.6 168
Change - -88.05% 818.1% 44.74% -1.95% 42.49% -23.47% 2.1%
Announcement Date 26/1/22 2/2/23 31/1/24 5/2/25 28/1/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: CONMED Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 19.51% 18.05% 18.92% 20.32% 20.07% 20.78% 20.77% 20.47%
EBIT Margin (%) 14.18% 12.55% 14.01% 15.51% 15.71% 15.9% 16.01% 16.42%
EBT Margin (%) - - - 12.47% 5.17% 13.44% 13.93% -
Net margin (%) 6.19% -7.71% 5.18% 10.13% 3.42% 8.4% 9.59% 9.36%
FCF margin (%) 9.59% 1.11% 8.54% 11.77% 10.98% 15.78% 11.54% 11.2%
FCF / Net Income (%) 154.94% -14.37% 164.94% 116.21% 320.65% 187.92% 120.3% 119.69%

Profitability

        
ROA 5.65% 4.04% 4.71% 5.75% 6.18% 5.91% 5.65% 5.86%
ROE 13.3% 10.71% 13.71% 14.74% 14.34% 12.89% 11.33% 11.19%

Financial Health

        
Leverage (Debt/EBITDA) 3.37x 5.44x 4.03x 3.32x 2.88x 2.62x 2.18x 1.73x
Debt / Free cash flow 6.85x 88.59x 8.93x 5.73x 5.26x 3.45x 3.92x 3.17x

Capital Intensity

        
CAPEX / Current Assets (%) 1.47% 2.08% 1.53% 1% 1.44% 1.39% 1.89% 1.87%
CAPEX / EBITDA (%) 7.54% 11.54% 8.08% 4.93% 7.18% 6.71% 9.11% 9.12%
CAPEX / FCF (%) 15.34% 188.13% 17.9% 8.5% 13.13% 8.84% 16.41% 16.67%

Items per share

        
Cash flow per share 1 - 1.111 3.973 5.36 5.48 4.198 6.217 -
Change - - 257.72% 34.91% 2.23% -23.4% 48.1% -
Dividend per Share 1 0.8 0.8 0.8 0.8 0.8 - - -
Change - 0% 0% 0% 0% - - -
Book Value Per Share 1 26.93 24.82 27.12 31.15 36.87 38 43.15 49.19
Change - -7.85% 9.26% 14.89% 18.36% 3.05% 13.55% 14.01%
EPS 1 1.94 -2.68 2.04 4.25 1.51 3.79 4.515 4.64
Change - -238.14% 176.12% 108.33% -64.47% 150.99% 19.13% 2.77%
Nbr of stocks (in thousands) 29,247 30,482 30,752 30,891 30,968 29,803 29,803 29,803
Announcement Date 26/1/22 2/2/23 31/1/24 5/2/25 28/1/26 - - -
1USD
Estimates
2026 *2027 *
P/E 11.7x 9.81x
PBR 1.17x 1.03x
EV / Sales 1.51x 1.38x
Yield - -

EPS & Dividend

EPS & Dividend - CONMED Corporation


Y-o-Y evolution of P/E

Valuation ratios - P/E - CONMED Corporation
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - CONMED Corporation
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - CONMED Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
44.29USD
Average target price
46.83USD
Spread / Average Target
+5.74%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CONMED Corporation
  1. Stock Market
  2. Stocks
  3. CNMD Stock
  4. Financials CONMED Corporation